Literature DB >> 14667505

Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma.

Jason A Hoffman1, Enrico Giraudo, Mallika Singh, Lianglin Zhang, Masahiro Inoue, Kimmo Porkka, Douglas Hanahan, Erkki Ruoslahti.   

Abstract

Phage display was used to identify homing peptides for blood vessels in a mouse model of HPV16-induced epidermal carcinogenesis. One peptide, CSRPRRSEC, recognized the neovasculature in dysplastic skin but not in carcinomas. Two other peptides, with the sequences CGKRK and CDTRL, preferentially homed to neovasculature in tumors and, to a lesser extent, premalignant dysplasias. The peptides did not home to vessels in normal skin, other normal organs, or the stages in pancreatic islet carcinogenesis in another mouse model. The CGKRK peptide may recognize heparan sulfates in tumor vessels. The dysplasia-homing peptide is identical to a loop in kallikrein-9 and may bind a kallikrein inhibitor or substrate. Thus, characteristics of the angiogenic vasculature distinguish premalignant and malignant stages of skin tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14667505     DOI: 10.1016/s1535-6108(03)00273-3

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  72 in total

1.  Multifunctional theranostic nanoparticles for brain tumors.

Authors:  Yuhua Wang; Leaf Huang
Journal:  Mol Ther       Date:  2012-01       Impact factor: 11.454

Review 2.  Silk-based delivery systems of bioactive molecules.

Authors:  Keiji Numata; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2010-03-16       Impact factor: 15.470

3.  In vivo imaging of molecularly targeted phage.

Authors:  Kimberly A Kelly; Peter Waterman; Ralph Weissleder
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

4.  Molecular changes in the vasculature of injured tissues.

Authors:  Tero A H Järvinen; Erkki Ruoslahti
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

Review 5.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

6.  Tissue-penetrating delivery of compounds and nanoparticles into tumors.

Authors:  Kazuki N Sugahara; Tambet Teesalu; Priya Prakash Karmali; Venkata Ramana Kotamraju; Lilach Agemy; Olivier M Girard; Douglas Hanahan; Robert F Mattrey; Erkki Ruoslahti
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

7.  Targeting of albumin-embedded paclitaxel nanoparticles to tumors.

Authors:  Priya Prakash Karmali; Venkata Ramana Kotamraju; Mark Kastantin; Matthew Black; Dimitris Missirlis; Matthew Tirrell; Erkki Ruoslahti
Journal:  Nanomedicine       Date:  2008-10-01       Impact factor: 5.307

Review 8.  Mouse models for studying angiogenesis and lymphangiogenesis in cancer.

Authors:  Lauri Eklund; Maija Bry; Kari Alitalo
Journal:  Mol Oncol       Date:  2013-03-05       Impact factor: 6.603

9.  Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy.

Authors:  Pei-Lin Hsiung; Pei-Lei Hsiung; Jonathan Hardy; Shai Friedland; Roy Soetikno; Christine B Du; Amy P Wu; Peyman Sahbaie; James M Crawford; Anson W Lowe; Christopher H Contag; Thomas D Wang
Journal:  Nat Med       Date:  2008-03-16       Impact factor: 53.440

10.  Influence of the dye presence on the conformational preferences of CREKA, a tumor homing linear pentapeptide.

Authors:  David Zanuy; David Curcó; Ruth Nussinov; Carlos Alemán
Journal:  Biopolymers       Date:  2009       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.